US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist

2.4200
+0.0200+0.83%

Close Oct 2 16:00 ET

3.46MMarket Cap0.06P/E (TTM)

Avenue Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-28.04%2.82M

-42.32%3.71M

80.78%14.54M

-45.83%2.12M

211.92%2.07M

548.43%3.92M

124.55%6.43M

115.17%8.04M

328.01%3.91M

-23.97%663K

Selling and administrative expenses

63.17%1.46M

33.74%1.32M

-21.81%4.18M

-66.23%1.14M

147.55%1.16M

97.36%896K

-6.73%984K

115.18%5.35M

542.56%3.37M

-21.04%469K

-General and administrative expense

63.17%1.46M

33.74%1.32M

-21.81%4.18M

-66.23%1.14M

147.55%1.16M

97.36%896K

-6.73%984K

115.18%5.35M

542.56%3.37M

-21.04%469K

Research and development costs

-55.04%1.36M

-56.07%2.39M

284.03%10.36M

80.18%982K

367.53%907K

1,904.64%3.03M

201.16%5.45M

115.15%2.7M

39.74%545K

-30.22%194K

Operating profit

28.04%-2.82M

42.32%-3.71M

-80.78%-14.54M

45.83%-2.12M

-211.92%-2.07M

-548.43%-3.92M

-124.55%-6.43M

-115.17%-8.04M

-328.01%-3.91M

23.97%-663K

Net non-operating interest income expense

-8.77%52K

116.61%49K

81.93%-206K

101.92%22K

800.00%9K

5,600.00%57K

-14,850.00%-295K

-16,385.71%-1.14M

-114,500.00%-1.14M

0.00%1K

Non-operating interest income

-8.77%52K

32.43%49K

530.00%126K

37.50%22K

800.00%9K

5,600.00%57K

1,750.00%37K

185.71%20K

1,500.00%16K

0.00%1K

Non-operating interest expense

--0

-71.38%332K

--0

--332K

--1.16M

--0

Other net income (expense)

146.67%70K

21.41%-690K

-23.69%4.26M

2.71M

2.57M

-150K

-878K

5.58M

Gain on sale of security

146.67%70K

21.41%-690K

-23.69%4.26M

--2.71M

--2.57M

---150K

---878K

--5.58M

----

Income before tax

32.74%-2.7M

42.79%-4.35M

-191.09%-10.49M

17.75%617K

177.49%513K

-564.90%-4.02M

-165.71%-7.6M

3.43%-3.6M

157.39%524K

24.00%-662K

Income tax

Net income

32.74%-2.7M

42.79%-4.35M

-191.09%-10.49M

17.75%617K

177.49%513K

-564.90%-4.02M

-165.71%-7.6M

3.43%-3.6M

157.39%524K

24.00%-662K

Net income continuous Operations

32.74%-2.7M

42.79%-4.35M

-191.09%-10.49M

17.75%617K

177.49%513K

-564.90%-4.02M

-165.71%-7.6M

3.43%-3.6M

157.39%524K

24.00%-662K

Minority interest income

0.00%-9K

86.36%-9K

-117.65%-111K

54.90%-23K

-13K

-9K

-66K

-51K

Net income attributable to the parent company

-79.34%-7.19M

42.41%-4.34M

-192.15%-10.38M

11.30%640K

179.46%526K

-563.41%-4.01M

-163.40%-7.54M

4.80%-3.55M

162.98%575K

24.00%-662K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-79.34%-7.19M

42.41%-4.34M

-192.15%-10.38M

11.30%640K

179.46%526K

-563.41%-4.01M

-163.40%-7.54M

4.80%-3.55M

162.98%575K

24.00%-662K

Basic earnings per share

83.40%-6.43

84.84%-15.4

39.88%-73.5

-79.24%1.8752

113.33%4.5

-25.98%-38.74

33.94%-101.57

50.46%-122.25

116.28%9.0336

43.04%-33.75

Diluted earnings per share

83.40%-6.43

84.84%-15.4

39.88%-73.5

-79.24%1.8752

113.33%4.5

-25.98%-38.74

33.94%-101.57

50.46%-122.25

116.28%9.0336

43.04%-33.75

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-28.04%2.82M	-42.32%3.71M	80.78%14.54M	-45.83%2.12M	211.92%2.07M	548.43%3.92M	124.55%6.43M	115.17%8.04M	328.01%3.91M	-23.97%663K
Selling and administrative expenses	63.17%1.46M	33.74%1.32M	-21.81%4.18M	-66.23%1.14M	147.55%1.16M	97.36%896K	-6.73%984K	115.18%5.35M	542.56%3.37M	-21.04%469K
-General and administrative expense	63.17%1.46M	33.74%1.32M	-21.81%4.18M	-66.23%1.14M	147.55%1.16M	97.36%896K	-6.73%984K	115.18%5.35M	542.56%3.37M	-21.04%469K
Research and development costs	-55.04%1.36M	-56.07%2.39M	284.03%10.36M	80.18%982K	367.53%907K	1,904.64%3.03M	201.16%5.45M	115.15%2.7M	39.74%545K	-30.22%194K
Operating profit	28.04%-2.82M	42.32%-3.71M	-80.78%-14.54M	45.83%-2.12M	-211.92%-2.07M	-548.43%-3.92M	-124.55%-6.43M	-115.17%-8.04M	-328.01%-3.91M	23.97%-663K
Net non-operating interest income expense	-8.77%52K	116.61%49K	81.93%-206K	101.92%22K	800.00%9K	5,600.00%57K	-14,850.00%-295K	-16,385.71%-1.14M	-114,500.00%-1.14M	0.00%1K
Non-operating interest income	-8.77%52K	32.43%49K	530.00%126K	37.50%22K	800.00%9K	5,600.00%57K	1,750.00%37K	185.71%20K	1,500.00%16K	0.00%1K
Non-operating interest expense	--0	--0	-71.38%332K	--0	--0	--0	--332K	--1.16M	--1.16M	--0
Other net income (expense)	146.67%70K	21.41%-690K	-23.69%4.26M	2.71M	2.57M	-150K	-878K	5.58M
Gain on sale of security	146.67%70K	21.41%-690K	-23.69%4.26M	--2.71M	--2.57M	---150K	---878K	--5.58M	----	----
Income before tax	32.74%-2.7M	42.79%-4.35M	-191.09%-10.49M	17.75%617K	177.49%513K	-564.90%-4.02M	-165.71%-7.6M	3.43%-3.6M	157.39%524K	24.00%-662K
Income tax
Net income	32.74%-2.7M	42.79%-4.35M	-191.09%-10.49M	17.75%617K	177.49%513K	-564.90%-4.02M	-165.71%-7.6M	3.43%-3.6M	157.39%524K	24.00%-662K
Net income continuous Operations	32.74%-2.7M	42.79%-4.35M	-191.09%-10.49M	17.75%617K	177.49%513K	-564.90%-4.02M	-165.71%-7.6M	3.43%-3.6M	157.39%524K	24.00%-662K
Minority interest income	0.00%-9K	86.36%-9K	-117.65%-111K	54.90%-23K	-13K	-9K	-66K	-51K	-51K	0
Net income attributable to the parent company	-79.34%-7.19M	42.41%-4.34M	-192.15%-10.38M	11.30%640K	179.46%526K	-563.41%-4.01M	-163.40%-7.54M	4.80%-3.55M	162.98%575K	24.00%-662K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-79.34%-7.19M	42.41%-4.34M	-192.15%-10.38M	11.30%640K	179.46%526K	-563.41%-4.01M	-163.40%-7.54M	4.80%-3.55M	162.98%575K	24.00%-662K
Basic earnings per share	83.40%-6.43	84.84%-15.4	39.88%-73.5	-79.24%1.8752	113.33%4.5	-25.98%-38.74	33.94%-101.57	50.46%-122.25	116.28%9.0336	43.04%-33.75
Diluted earnings per share	83.40%-6.43	84.84%-15.4	39.88%-73.5	-79.24%1.8752	113.33%4.5	-25.98%-38.74	33.94%-101.57	50.46%-122.25	116.28%9.0336	43.04%-33.75
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data